GENEVA, July 6 -- SHENYANG XINGQI PHARMACEUTICAL CO., LTD. filed a patent application (CN2025/144765) for “PREPARATION AND USE OF COMPOUND CAPABLE OF INHIBITING MYOPIA PROGRESSION”. With publication no. WO/2026/138799, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07D 311/02
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....